June 2023
-
06.22.2023 Vaccines Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-valent Pneumococcal Conjugate Vaccine) in Infants and Children -
06.22.2023 Vaccines Pfizer’s ABRYSVO™ Receives Recommendation for Use in Older Adults from Advisory Committee on Immunization Practices -
06.05.2023 Medicines Pfizer Announces DUAVEE® (conjugated estrogens/bazedoxifene), an Estrogen-Based Menopause Hormone Therapy, Now Back in Stock with Improved Packaging
May 2023
-
05.26.2023 Vaccines Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission -
05.11.2023 Covid-19 Diseases & Conditions Health Equity Vaccines Global and U.S. Agencies Declare End of COVID-19 Emergency
February 2023
-
02.17.2023 Vaccines Pfizer and Valneva Issue Update on Phase 3 Clinical Trial Evaluating Lyme Disease Vaccine Candidate VLA15 -
02.10.2023 Research Vaccines Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program
January 2023
-
01.30.2023 Leadership Medicines Partnerships Responsibility Pfizer and International Trachoma Initiative Deliver One Billionth Zithromax® Dose Toward Trachoma Elimination by 2030 -
01.27.2023 Research Pfizer Responds to Research Claims -
01.27.2023 Covid-19 Medicines Pfizer Receives Positive CHMP Opinion for Conversion of PAXLOVID™ Conditional Marketing Authorization to Full Marketing Authorization in the European Union -
01.17.2023 Investments Pfizer to Acquire Sanford, North Carolina Manufacturing Site from Abzena